sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq data

Feng, Jiarui and Goedegebuure, S. Peter and Zeng, Amanda and Bi, Ye and Wang, Ting and Payne, Philip and Ding, Li and DeNardo, David and Hawkins, William and Fields, Ryan C. and Li, Fuhai and Xie, Lei (2024) sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq data. PLOS Computational Biology, 20 (1). e1011785. ISSN 1553-7358

[thumbnail of journal.pcbi.1011785.pdf] Text
journal.pcbi.1011785.pdf - Published Version

Download (3MB)

Abstract

Single-cell RNA sequencing (scRNA-seq) is a powerful technology to investigate the transcriptional programs in stromal, immune, and disease cells, like tumor cells or neurons within the Alzheimer’s Disease (AD) brain or tumor microenvironment (ME) or niche. Cell-cell communications within ME play important roles in disease progression and immunotherapy response and are novel and critical therapeutic targets. Though many tools of scRNA-seq analysis have been developed to investigate the heterogeneity and sub-populations of cells, few were designed for uncovering cell-cell communications of ME and predicting the potentially effective drugs to inhibit the communications. Moreover, the data analysis processes of discovering signaling communication networks and effective drugs using scRNA-seq data are complex and involve a set of critical analysis processes and external supportive data resources, which are difficult for researchers who have no strong computational background and training in scRNA-seq data analysis. To address these challenges, in this study, we developed a novel open-source computational tool, sc2MeNetDrug (https://fuhaililab.github.io/sc2MeNetDrug/). It was specifically designed using scRNA-seq data to identify cell types within disease MEs, uncover the dysfunctional signaling pathways within individual cell types and interactions among different cell types, and predict effective drugs that can potentially disrupt cell-cell signaling communications. sc2MeNetDrug provided a user-friendly graphical user interface to encapsulate the data analysis modules, which can facilitate the scRNA-seq data-based discovery of novel inter-cell signaling communications and novel therapeutic regimens.

Item Type: Article
Subjects: Universal Eprints > Biological Science
Depositing User: Managing Editor
Date Deposited: 23 Mar 2024 08:39
Last Modified: 23 Mar 2024 08:39
URI: http://journal.article2publish.com/id/eprint/3688

Actions (login required)

View Item
View Item